Drug · DIN 02487756
BIBAG
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 26, 2022; first marketed January 30, 2020.
- Drug Identification Number (DIN)
- 02487756
- Company (DIN owner)
- Fresenius Medical Care Canada IncRichmond Hill, Ontario, Canada
- Schedule
- Ethical
- Dosage form
- Powder For Solution
- Route
- Haemodialysis
- Therapeutic class (ATC)
- Hemodialytics, concentrates B05ZA
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SODIUM BICARBONATE | 900 G | BAG |
Other DINs named BIBAG
- DIN 02325586 · Marketed